Table 4. Main published studies (2006–2013) reporting distribution of Mycobacterium tuberculosis lineages in Central and South America.
| Country, Period (years) and Reference | Numbe of strains | Harleem (H) | T | LAM | S | U | Beijing | X | EAI | Orphans or Unclassified |
|---|---|---|---|---|---|---|---|---|---|---|
| Argentina, 2006–2007 [22] | 157 | 37% | 18% | 23% | NR | NR | NR | NR | NR | NA |
| H1 10% | T1 18% | LAM9 13% | ||||||||
| H2 16% | LAM3 10% | |||||||||
| H3 11% | ||||||||||
| Argentina, 2003–2009 [51] | 787 (MDR only) | 36.3% | 13.9% | 38.8% | 2.8% | 1.7% | 1.5% | 0.9% | NR | 3.8% |
| T1 8.9% | LAM3 16.4% | |||||||||
| Argentina, Brasil, Chile, Colombia, Venezuela, 2004–2008 [52] | 951 (MDR only) | 28.9% | 17.4% | 37.2% | NR | NR | 1.3% | NR | NR | NR |
| French Guyane, 1994–2003 [34] | 744 | 21.7% | 30.1% | 19.7% | 1.5% | NR | 1.0% | 6.5% | 4.8% | 6.5% |
| Brasil, 1996–2005 [21] | 1991 | 12.2% | 18.6% | 46% | 1.9% | NR | NR | 4.7% | 0.85% | 15% |
| LAM9 10.3% | ||||||||||
| Colombia 1995–2007[23] | 152 | 25% | 13.8% | 49.3% | 3.3% | NR | 0.6% | 1.3% | NR | 6.6% |
| Colombia 2005–2008 [33] | 414 | 44.3% | 38.5% | 0 | ||||||
| H1 23.4% | LAM9:29.9% | |||||||||
| Paraguay, 2003 [39] | 220 | 18.2% | 8.6% | 52.3% | 9.5% | NR | 0.5% | 0.9% | NR | NR |
| Peru, 1996–2004 [24] | 391 (MDR only) | 11.4% | 27.5% | 33.3% | NR | 0.3% | 4.9% | 4.4% | NR | 18% |
| H1 5.7% | T1 22.1% | LAM5 12.2% | X3 4.4% | |||||||
| H3 5.7% | T2 4.9% | LAM9 9.9% | ||||||||
| T5 0.5% | LAM1 6.5% | |||||||||
| Peru, 2004–2006 [25] | 323 | 23.8% | 22.3% | 23.8% | NR | NR | 9.3% | NR | NR | 13.3% |
| Peru, 2009 [26] | 199 | 34.9% | 15.6% | 12.6% | 1.0% | 8.5% | 14.1% | 3.5% | NR | 15.1% |
| Peru, 1999–2005[27] | 794 | H3 16.4% | T1 12.3% | 18.7% | NR | NR | 5.5% | 2.8% | NR | 3.4% |
| H1 3.9% | LAM3 8.3% | |||||||||
| LAM9 7.4% | ||||||||||
| Venezuela, 1998–1999 [38] | 670 | 3% | 13% | 74% | 1.0% | NR | 0% | NR | NR | 9% |
| Venezuela, 1997–2006 [40] | 1298 | 5% | 10.6% | 53% | 1.9% | 9.7% | 0.4% | 1.2% | 0.2% | 17.9% |
| Bolivia, 2010 [30] | 99 | 39.4% | 22.2% | 26.3% | 2% | NR | NR | 1% | NR | 9.1% |
| H3 30.3% | T1 21.2% | LAM3 15.2% |